[Argon laser iridotomy in neovascular glaucoma]

Area of Science:

• Ophthalmology
• Glaucoma Research
• Laser Therapy

Context:

• Neovascular glaucoma (NVG) presents a significant challenge, particularly when superimposed on chronic primary angle-closure glaucoma (PACG).
• NVG, often stemming from proliferative diabetic retinopathy or central retinal vein occlusion, necessitates effective management strategies to prevent vision loss.
• The anterior segment of the eye is critically affected in these conditions, leading to increased intraocular pressure and potential optic nerve damage.

Purpose:

• To assess the long-term efficacy and safety of argon laser iridotomy (ALI) in patients with NVG and a history of PACG.
• To evaluate the structural changes in the anterior chamber following ALI treatment in this specific patient cohort.
• To compare the outcomes of ALI with other potential interventions for managing NVG in the context of PACG.

Summary:

• This study evaluated 186 glaucomatous eyes from 160 patients with a 10-year history of chronic PACG who developed secondary NVG.
• Patients underwent ALI using specific parameters: preparatory stretch burns (200 μ spot, 0.2 sec, 200 mW) followed by penetration burns (50 μ spot, 0.2 sec, 1000 mW) until transillumination.
• Results showed that ALI led to iris repositioning and peripheral anterior chamber deepening in 90% of treated eyes.

Impact:

• Argon laser iridotomy provides a safe and effective method for deepening the anterior chamber in eyes with NVG associated with PACG.
• The procedure demonstrates a high success rate in structural modification of the anterior segment, potentially improving glaucomatous conditions.
• ALI emerges as a preferred treatment option over other methods for this complex glaucoma subtype, offering a favorable risk-benefit profile.